• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21797 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness research of computer-assisted navigation in knee arthroplasty]
2013     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness of medication therapies in the rheumatoid arthritis patients]
2014     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Comparative effectiveness of conservative treatment of breast cancer with brachytherapy and external beam radiation]
2016     National Evidence-based Healthcare Collaborating Agency (NECA) [Comparative effectiveness of carbapenems and alternative antibiotics for the treatment of bacteraemia and/or urinary tract infectious disease by Enterobacteriaceae producing extended-spectrum β-lactamase]
2009     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Comparative analysis of thermal disinfection with a washer-disinfector and pasteurization: anaesthesia and respiratory devices]
2014     Andalusian Health Technology Assessment Area (AETSA) [Communication strategies with children and adolescents in the hospital or primary care setting]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Combined screening for early diagnosis of chromosomal abnormalities during the first trimester of pregnancy]
2023     Institute for Clinical Effectiveness and Health Policy (IECS) [Combination diagnostic tests offered as part of preventive health checks exams in overall population]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Colorectal cancer screening in persons with a relevant family history - Update to commission S11-01]
2000     Finnish Office for Health Care Technology Assessment (Finohta) [Colorectal cancer screening in Finland: conditions and effects]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Colongraphy compared with conventional colonoscopy]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Colon examination with CT colonography - a health technology assessment]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Colon cancer investigation, treatment and follow-up algorithm (update)]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Collagen-covered and periosteum-covered autologous chondrocyte implantation in the knee joint as well as matrix-associated autologous chondrocyte implantation in the knee joint]
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [Collaboration Research for development of Trustworthy Clinical Practice Guidelines and evaluation of implementation]
2013     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Colestilan - Benefit assessment according to § 35a Social Code Book V (dossier assessment)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cold plasma in wound therapy]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cold plasma in wound therapy (Addendum to Commission E21-03)]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cold plasma in wound therapy (2nd addendum to Commission E21-03)]
2008     Committee for New Health Technology Assessment (CNHTA) [COL3A1 gene mutation analysis]
2008     Committee for New Health Technology Assessment (CNHTA) [COL2A1 gene, mutation[sequencing]]
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Coherent monitoring and follow-up of pregnant women with a heart disease - a Health Technology Assessment]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Cognitive rehabilitation in secondary cognitive impairment]
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Cognitive rehabilitation in cognitive deficit secondary to stroke]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cognitive behavioural therapy for insomnia - Evidence report for the S3 guideline on non-restorative sleep/sleep disorders - Insomnia in adults]
2008     Center for Medical Technology Assessment (CMT) [Cognitive assistive technologies for persons with dementia - cost-effectiveness and quality of prescription process]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobimetinib: addendum to commission A15-52]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobimetinib - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobicistat (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2009     Committee for New Health Technology Assessment (CNHTA) [CoaguChek XS PT TEST]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [CO2 Laser surgery in patients with otosclerosis]
2019     Basque Office for Health Technology Assessment (OSTEBA) [Closed vs open systems for the preparation and administration of cytostatic and other hazardous drugs (NIOSH Group 1): analysis of the scientific evidence, costs and organisational requirements]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clopidogrel, prasugrel, and ticagrelor for the prevention of atherothrombotic events in acute coronary syndrome]
2006     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clopidogrel versus acetylsalicylic acid for the secondary prevention of vascular diseases]
2009     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Clopidogrel plus acetylsalicylic acid in acute coronary syndrome]
2012     National Evidence-based Healthcare Collaborating Agency (NECA) [Clinically relevant venous thromboembolism following hip and knee arthroplasty]
2013     Haute Autorite de sante (HAS) [Clinical utility of the measurement of vitamin D]
2021     Andalusian Health Technology Assessment Area (AETSA) [Clinical utility of optical coherence tomography angiography in exudative age-related macular degeneration management]
2014     National Evidence-based Healthcare Collaborating Agency (NECA) [Clinical safety and effectiveness of robotic surgery (2)]
2020     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guidelines on the diagnosis and treatment of non-serious blunt chest trauma]
2018     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guidelines on severe mental disorder]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guidelines on lipid management as a cardiovascular risk factor]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guidelines on arterial hypertension (2007 update)]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guidelines for hemotherapy. Brief report]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on type 2 diabetes]
2012     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on type 1 diabetes]
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on the management of vasomotor and vaginal symptoms associated with menopause and postmenopause]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on the management of head injury in the field of extra and initial hospital care]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on the diagnostic, treatment and prevention of tuberculosis]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical Practice Guideline on the care for people with alzheimer's disease and dementia]
2012     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Practice Guideline on prevention and management of suicidal behaviour]
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on palliative care]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on osteoporosis and prevention of fragility fractures]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on low back pain]
2014     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on intravenous therapy with temporary devices in adults]
2015     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guideline on Childhood Asthma]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on borderline personality disorders]
2005     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on asthma]
2010     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on assistance at normal childbirth]
2021     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Practice Guideline on adult's palliative care]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline on acute bronchiolitis]
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline of care for people with multiple sclerosis]
2001     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline for medical management of otitis media in childhood]
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Clinical practice guideline for attention deficit hyperactivity disorder (ADHD) in children and adolescents]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical Practice Guideline about breastfeeding]
2007     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical impact of capsule endoscopy in obscure gastrointestinal bleeding. Systematic review]
2012     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical guides in antibiotic treatment, 2nd series]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical guides in antibiotic treatment – 1st series (update)]
2022     Andalusian Health Technology Assessment Area (AETSA) [Clinical effectiveness, safety, and economic assessment of mass screening for hepatitis C. Systematic review]
2021     Health Sciences Institute in Aragon (IACS) [Clinical effectiveness of sFlt-1 to PlGF ratio tests for the evaluation of preeclampsia]
2020     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Clinical effectiveness of pulse oximetry for neonatal screening of critical congenital heart diseases]
2009     Andalusian Health Technology Assessment Area (AETSA) [Clinical effectiveness of ozone therapies]
2009     Andalusian Health Technology Assessment Area (AETSA) [Clinical effectiveness of ozone therapies]
2018     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for severe combined immunodeficiency]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: β-ketothiolase deficiency (BKT); 3-hydroxy-3-methyl glutaric aciduria (HMG)]
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part III: carnitine uptake deficiency (CUD); short-chain acyl-CoA dehydrogenase deficiency (SCADD); very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2013     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2007     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry. Systematic Review]
2005     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Clinical effectiveness of indapamide; systematic review of the clinical and economic literature]
2005     Unit of Health Economics and Technology Assessment in Health Care (HunHTA) [Clinical effectiveness of carvedilol in comparison to -blockers, systematic review of the clinical and economic literature]
2013     National Evidence-based Healthcare Collaborating Agency (NECA) [Clinical effectiveness and safety of robotic surgery]
2017     Basque Office for Health Technology Assessment (OSTEBA) [Clinical effectiveness and cost-effectiveness of non-invasive telemonitoring on patients with heart failure]
2014     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Clinical effectiveness and cost-effectiveness of fissure sealants in children and adolescents with a high caries risk]
2012     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Clinical effectiveness and cost-effectiveness of central venous catheters treated with minocycline and rifampicin in preventing bloodstream infections in intensive care patients]
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Clavicular fractures - a systematic review about efficacy and safety of different treatment options]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Classification of disease severity for neuro- and trauma rehabilitation Part 3: Status quo in Austria]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cladribine (multiple sclerosis) - Benefit assessment according to §35a Social Code Book (SGB) V]
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Circulating tumour cells in breast cancer: clinical use of the CellSearch® test]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cipaglucosidase alfa (Pompe disease) – Benefit assessment according to § 35a Social Code Book (SGB) V]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cipaglucosidase alfa (Pompe disease) – Addendum to Project A23-79]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ciltacabtagene autoleucel (multiple myeloma) - Assessment according to §35a (para. 1, sentence 11) Social Code Book V]
2010     The Swedish Council on Health Technology Assessment (SBU) [Cilostazol for treatment of intermittent claudication]
2013     Institute for Clinical Effectiveness and Health Policy (IECS) [Cidofovir for the treatment of recurrent respiratory papillomatosis]
2014     The Swedish Council on Health Technology Assessment (SBU) [Chronic ulcers in the elderly – prevention and treatment]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Chronic periodontitis - prevention, diagnosis and treatment]